Blueprint Medicines Competitors and Similar CompaniesClear all

Blueprint Medicines's competitors and similar companies include Halozyme Therapeutics, Deciphera Pharmaceuticals, Repare Therapeutics and AstraZeneca United States.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Repare Therapeutics
Repare Therapeutics
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
AstraZeneca United States
AstraZeneca United States
AstraZeneca United States is a biopharmaceutical company.
Founding Date
Founding Date
2011
Founding Date
1998
Founding Date
2003
Founding Date
2016
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Cambridge, US HQ
Amsterdam, NL
Lugano, CH
Zug, CH
Locations
San Diego, US HQ
Locations
Waltham, US HQ
Lawrence, US
Locations
Montréal, CA HQ
Cambridge, US
Locations
Wilmington, US HQ
Gaithersburg, US
Employees
Employees
49515% increase
Employees
1457% increase
Employees
35037% increase
Employees
180
Employees
N/A
Valuation ($)
Valuation ($)
5.5 b
Valuation ($)
4.6 b
Valuation ($)
1.3 b
Valuation ($)
279.3 m
Valuation ($)
N/A
Twitter followers
Twitter followers
2.8 k
Twitter followers
423
Twitter followers
783
Twitter followers
1 k
Twitter followers
83.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.7
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
80%
Employee Rating
Employee Rating
4.2
Employee Rating
3.1
Employee Rating
3.7
Employee Rating
4.9
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$249.4m (FY, 2023)
Revenue (est.)
$660.1m (FY, 2022)
Revenue (est.)
$163.4m (FY, 2023)
Revenue (est.)
$131.8m (FY, 2022)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$8.5m (FY, 2023)
Cost of goods
$139.3m (FY, 2022)
Cost of goods
$3.7m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$240.8m (FY, 2023)
Gross profit
$520.8m (FY, 2022)
Gross profit
$159.6m (FY, 2023)
Gross profit
$131.8m (FY, 2022)
Gross profit
N/A
Net income
Net income
($507m) (FY, 2023)
Net income
$202.1m (FY, 2022)
Net income
($194.9m) (FY, 2023)
Net income
($29m) (FY, 2022)
Net income
N/A

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
50 (FY, 2020)
Patent Applications
49 (Aug, 2017)
Patent Applications
N/A
Patent Applications
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
43 (FY, 2020)
Patents (US)
11 (Aug, 2017)
Patents (US)
N/A
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
$ 1.7b
Total funding raised
$ 171.9m
Total funding raised
$ 714m
Total funding raised
$ 150.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Halozyme Therapeutics
HQ
San Diego, US
Employees
145↑ 7% increase

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company
Repare Therapeutics
HQ
Montréal, CA
Employees
180

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.

View company
AstraZeneca United States
HQ
Wilmington, US

AstraZeneca United States is a biopharmaceutical company.

View company